About us
GloPID-R brings together funding bodies investing in research related to new or re-emerging infectious diseases.
GloPID-R is the only alliance of its kind to bring together research funding organizations on a global scale to facilitate an effective and rapid research of a significant outbreak of a new or re-emerging infectious disease with epidemic and pandemic potential.
The need for the rapid development of essential diagnostics, vaccines and therapeutics at the outset of an emerging infectious disease outbreak was highlighted when Ebola struck in West Africa in 2014 and has been confirmed in the battle against COVID-19. This pandemic has underlined the importance of planning and investing in research and innovation before a health crisis occurs.
The COVID-19 pandemic, epidemics like Ebola, Zika, yellow fever, and the plague outbreak in Madagascar have shown the importance of rapidly funding research. Find out how GloPID-R has mobilized science through our response to these outbreaks.
The G7 leaders “acknowledge the importance of ensuring mechanisms to accelerate R&D in public health emergencies, and welcome the action to prevent epidemics such as WHO Blueprint, discussions at Global Health Security Initiative and Global Research Collaboration for Infectious Disease Preparedness (GloPID-R).
Until now there has been no platform for scientists and research funders to identify the best research solutions and channel the necessary funds rapidly. GloPID-R is designed to save valuable resources, avoiding duplication of efforts and lost time.
29 of the world’s major research funders are represented in GloPID-R today.
GloPID-R does not fund projects directly but rather coordinates and shares information among the funding organizations. That way, research funders can jointly or separately target funds to specific infectious disease research programs. They also stay updated on each other’s research results and keep alert to emerging epidemics. Thanks to this cross-sharing of information, members of the GloPID-R network were immediately able to coordinate in response to the emergence of COVID-19, to identify the existing funded research projects in this area and rapidly launch emergency calls to support new, urgent scientific priorities.